| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0065-230X(08)60912-4 |
| P698 | PubMed publication ID | 7041539 |
| P2093 | author name string | Berenbaum MC | |
| P2860 | cites work | Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2 | Q28366028 |
| On the Interpretation of Multi-Hit Survival Curves | Q33710289 | ||
| Carcinogenic effects of chronic exposure to very low levels of toxic substances | Q35132368 | ||
| DRUG SYNERGISM IN ANTINEOPLASTIC CHEMOTHERAPY. | Q35457540 | ||
| Isobologram analysis of the combined effects of anti-tumour platinum complexes and ionizing radiation on mammalian cells | Q36044169 | ||
| SYNERGISTIC ACTION OF NITROGEN MUSTARD AND RADIATION IN MICROORGANISMS | Q36415980 | ||
| Cellular Responses to Combinations of Hyperthermia and Radiation | Q39619795 | ||
| Strategy for detection of cancer hazards to man† | Q39621690 | ||
| Approaches to the Combination Chemotherapy of Transplantable Neoplasms | Q40036184 | ||
| Additive Action of Ionizing and Non-ionizing Radiations Throughout the Chinese Hamster Cell-cycle | Q40645475 | ||
| The design and analysis of experiments for the assessment of drug interactions | Q40646424 | ||
| Overview of factors affecting drug interactions | Q40646434 | ||
| Effect of Ampicillin and Chloramphenicol Against Haemophilus influenzae | Q40675055 | ||
| Synergism of cefazolin-gentamicin against enterococci | Q40946925 | ||
| In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic | Q40947357 | ||
| Lethal interaction between ultraviolet-violet radiations and methyl methane sulphonate in repair proficient and repair deficient strains of Escherichia coli | Q41040488 | ||
| Dose-response curves for agents that impair cell reproductive integrity. A fundamental difference between dose-response curves or antimetabolites and those for radiation and alkylating agents | Q41414414 | ||
| Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity | Q41450560 | ||
| Lack of vincristine-cyclophosphamide potentiation in different experimental tumour lines | Q41554912 | ||
| Mutagenicity and toxicity of visible fluorescent light to cultured mammalian cells | Q43825134 | ||
| The Interaction of Near U.V. (365 nm) and X-radiations on Wild-type and Repair-deficient Strains ofEscherichia ColiK12: Physical and Biological Measurements | Q44245505 | ||
| A Method for Testing for Synergy with Any Number of Agents | Q44778227 | ||
| Asbestos Exposure, Smoking, and Neoplasia | Q45001296 | ||
| An analysis of the interaction between two nitrosourea compounds and X-radiation in rat brain tumour cells. | Q52766228 | ||
| Occam's razor pares the choice among statistical models. | Q52784871 | ||
| THE RELATION OF RADIATION DOSAGE TO ENHANCEMENT, DEPRESSION, AND RECOVERY OF THE INITIAL FORSSMAN HEMOLYSIN RESPONSE IN RABBITS. | Q53040036 | ||
| Potentiation of cigarette smoking and radiation: evidence from a sputum cytology survey among uranium miners and controls. | Q53577783 | ||
| Sister chromatid exchange as an indicator of mutagenesis | Q54587790 | ||
| Trimethoprim and rifampicin: in vitro activities separately and in combination | Q54620099 | ||
| Interaction of gamma-ray and neutron effects on the proliferative capacity of Chinese hamster cells | Q66875571 | ||
| Isobologram Analysis of X-Ray-BCNU Interactions in Vitro | Q66932922 | ||
| Terminology in the description of drug-radiation interactions | Q66985478 | ||
| In vitro systems: Standardization of endpoints | Q66985479 | ||
| Antibiotic interaction against Staphylococcus aureus; use of a new technique | Q66993810 | ||
| Interaction between radiation and drug damage in mammalian cells. I. Delayed expression of actinomycin D/x-ray effects in exponential and plateau phase cells | Q67295071 | ||
| Combined Effects of X Irradiation and Hyperthermia on CHO Cells for Various Temperatures and Orders of Application | Q67312328 | ||
| Synergistic lethal action of ultraviolet violet radiations and mild heat in Escherichia coli | Q67495244 | ||
| Mathematical simulation in chemotherapy | Q68484626 | ||
| Combination chemotherapy: The interaction of methotrexate and 5-fluorouracil | Q69058733 | ||
| The effect of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx | Q69406544 | ||
| Leukemia from low-level radiation: identification of susceptible children | Q70389702 | ||
| Radiosensitization with 5-Bromodeoxyuridine of Chinese Hamster Cells X-Irradiated during Different Phases of the Cell Cycle | Q70728062 | ||
| Repair of sub-lethal damage of L5178Y lymphoblasts in vitro treated with dimethyl myleran and nitrogen mustard | Q72045023 | ||
| Chromosome aberrations induced in human lymphocytes by ultrasoft Al (K) and C (K) X-rays | Q72083497 | ||
| Responses of yeast cells to heat applied alone or combined with gamma-rays | Q72088689 | ||
| The response of mouse intestine to combined hyperthermia and radiation: the contribution of direct thermal damage in assessment of the thermal enhancement ratio | Q72088723 | ||
| A modification of the sensitivity of mammalian cells surviving treatment with methyl methanesulphonate | Q72327521 | ||
| DARK RECOVERY PHENOMENA IN YEAST. II. CONDITIONS THAT MODIFY THE RECOVERY PROCESS | Q77142124 | ||
| Additivity of X-Rays and Ultraviolet Light in the Inactivation of Haploid and Diploid Yeast | Q78653677 | ||
| Effects of different radiations on human cells in tissue culture. II. Biological experiments | Q78789053 | ||
| Leukemia in children exposed to multiple risk factors | Q84551312 | ||
| The synergistic action of ultraviolet and x radiation on mutants of Escherichia coli K-12 | Q93747114 | ||
| P304 | page(s) | 269-335 | |
| P577 | publication date | 1981-01-01 | |
| P1433 | published in | Advances in Cancer Research | Q3113522 |
| P1476 | title | Criteria for analyzing interactions between biologically active agents | |
| P478 | volume | 35 |
| Q34942592 | A nonlinear isobologram model with Box-Cox transformation to both sides for chemical mixtures |
| Q91892259 | A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies |
| Q40023794 | A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis |
| Q106873492 | A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication |
| Q36457923 | A systems biology approach to uncovering pharmacological synergy in herbal medicines with applications to cardiovascular disease |
| Q42361379 | Additivity and Interactions in Ecotoxicity of Pollutant Mixtures: Some Patterns, Conclusions, and Open Questions. |
| Q53518731 | Adenovirus carrying TIMP-3: a potential tool for cervical cancer treatment. |
| Q40468799 | Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. |
| Q34722445 | Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation |
| Q33580906 | An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines |
| Q69626514 | Analysis of interaction for mixtures of agents using the linear isobole |
| Q55042256 | Analysis of synergism in hepatocarcinogenesis based on preneoplastic foci induction by 10 heterocyclic amines in the rat. |
| Q69003432 | Anti-HIV synergy between dextran sulphate and zidovudine |
| Q35224543 | Antibody Targeting as a Thrombolytic Strategy |
| Q38909188 | Antihelminthic benzimidazoles potentiate navitoclax (ABT-263) activity by inducing Noxa-dependent apoptosis in non-small cell lung cancer (NSCLC) cell lines |
| Q35110748 | Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores |
| Q41504777 | Antiproliferative effects of interferon gamma in combination with alpha-difluoromethylornithine on human carcinoma cell cultures |
| Q89977280 | Assessing the Effect of Mycotoxin Combinations: Which Mathematical Model Is (the Most) Appropriate? |
| Q34603025 | Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells |
| Q30495553 | Bcl-XL represents a druggable molecular vulnerability during aurora B inhibitor-mediated polyploidization |
| Q36694941 | Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice |
| Q43682296 | CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release |
| Q38341487 | CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction |
| Q41266661 | Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines |
| Q28768656 | Chemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on Carcinogens |
| Q36028986 | Chemosensitization by misonidazole in CCNU-treated spheroids and tumours |
| Q73085501 | Cisplatin combined with the new cisplatin-procaine complex DPR: in vitro and in vivo studies |
| Q38798785 | Co-targeting IGF-1R and c-kit: synergistic inhibition of proliferation and induction of apoptosis in H 209 small cell lung cancer cells |
| Q71613662 | Combinations of interferon with platinum complexes: synergistic and antagonistic effects on growth inhibition of MCF-7 and MDA-MB231 breast cancer cells |
| Q40628014 | Combined Therapy with Topotecan and Gemcitabine in Patients with Inoperable or Metastatic Non-small Cell Lung Cancer |
| Q36292810 | Combined effect of navelbine with medroxyprogesterone acetate against human breast carcinoma MCF-7 cells in vitro |
| Q39369141 | Combined inhibition of cellular pathways as a future therapeutic option in fatal anaplastic thyroid cancer |
| Q34478388 | Comparative Study of 17-AAG and NVP-AUY922 in Pancreatic and Colorectal Cancer Cells: Are There Common Determinants of Sensitivity? |
| Q39143106 | Constituents of the anti-asthma herbal formula ASHMI(TM) synergistically inhibit IL-4 and IL-5 secretion by murine Th2 memory cells, and eotaxin by human lung fibroblasts in vitro |
| Q24303657 | Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation |
| Q35688338 | Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts |
| Q36013320 | Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts |
| Q54359503 | Cytokines and pancreatic cancer. The effect of rIFN-gamma, HuLeIFN, rTNF-alpha, and LAK-cells on pancreatic and other gastrointestinal tumors in vitro. |
| Q43583267 | Death receptor-independent cytochrome c release and caspase activation mediate thymidine kinase plus ganciclovir-mediated cytotoxicity in LN-18 and LN-229 human malignant glioma cells |
| Q46333013 | Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma |
| Q34607270 | Detecting Departure From Additivity Along a Fixed-Ratio Mixture Ray With a Piecewise Model for Dose and Interaction Thresholds |
| Q39617420 | Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity |
| Q40907848 | Drug interaction: focusing on response surface models |
| Q36172596 | Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma |
| Q36135764 | Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo |
| Q41450635 | Effect of interferon gamma and tumour necrosis factor alpha on sensitivity to cisplatin in ovarian carcinoma cell lines |
| Q41399610 | Effect of tamoxifen on mitoxantrone cytotoxicity in drug-sensitive and multidrug-resistant MCF-7 cells |
| Q51448366 | Effect of the cisplatin-procaine complex DPR in combination with several anticancer agents on murine P388 leukemic cells in vitro and in vivo. |
| Q36562132 | Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alpha-fetoprotein in vitro and in vivo involving the NFkappaB- and the beta-catenin pathways. |
| Q35991863 | Effects of haematoporphyrin derivative and light in combination with hyperthermia on cells in culture |
| Q54393464 | Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay. |
| Q62977534 | Eicosanoid inhibitors enhance synergistically the effect of transforming growth factor β1 on CCL 64 cell proliferation |
| Q41133468 | Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells |
| Q55019227 | Enhancement of reversing effect of cyclosporin A on vincristine resistance by anti-P-glycoprotein monoclonal antibody MRK-16. |
| Q37278425 | Enhancement of taxol, doxorubicin and zoledronate anti-proliferation action on triple-negative breast cancer cells by a PTHrP blocking monoclonal antibody |
| Q39864163 | Environmental Risk Assessment of Pharmaceutical Mixtures: Demands, Gaps, and Possible Bridges |
| Q40885044 | Evaluating the antimicrobial activity of Nisin, Lysozyme and Ethylenediaminetetraacetate incorporated in starch based active food packaging film. |
| Q36671457 | Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative |
| Q73886817 | Identification of functional synergism between monoclonal antibodies. Application to the enhancement of plasminogen activator inhibitor-1 neutralizing effects |
| Q34620781 | Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib: a phase I-II study by the Spanish Group for Research on Sarcomas. |
| Q68548259 | Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase |
| Q34133637 | In vitro preclinical models for a rational design of chemotherapy combinations in human tumors |
| Q28367838 | Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomes |
| Q39578882 | Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins |
| Q39905584 | Inhibition of Aurora B kinase sensitizes a subset of human glioma cells to TRAIL concomitant with induction of TRAIL-R2. |
| Q39672272 | Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells |
| Q53677564 | Inhibition of S6K1 enhances dichloroacetate-induced cell death. |
| Q39990380 | Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells |
| Q36402832 | Inhibition of food intake |
| Q47898554 | Inhibition of in-vitro growth of Plasmodium falciparum by Pseudocedrela kotschyi extract alone and in combination with Fagara zanthoxyloides extract |
| Q24810622 | Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells |
| Q41703227 | Inhibition of protein synthesis enhances the lytic effects of tumor necrosis factor alpha and interferon gamma in cell lines derived from gynecological malignancies |
| Q51139025 | Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target. |
| Q41018406 | Inhibitors of lipoxygenase metabolism exert synergistic effects with retinoic acid on differentiation of human leukemia HL-60 cells |
| Q40800348 | Interaction of cytosine arabinoside and lovastatin in human leukemia cells |
| Q55266412 | Interaction of interleukin-1 and interferon-gamma on fibroblast growth factor-induced angiogenesis. |
| Q43925998 | Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay |
| Q42940138 | Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice |
| Q35579660 | JAK2V617F drives Mcl-1 expression and sensitizes hematologic cell lines to dual inhibition of JAK2 and Bcl-xL. |
| Q55114469 | Kinetic Analysis of Combination Effect of Navelbine (KW-2307) with Cisplatin against Human Lung Adenocarcinoma PC-12 Cells in Culture |
| Q73276141 | Macrophages From Cancer Patients: Analysis of TRAIL, TRAIL Receptors, and Colon Tumor Cell Apoptosis |
| Q39493977 | Membrane-mimicking entities induce structuring of the two-peptide bacteriocins plantaricin E/F and plantaricin J/K. |
| Q33637374 | Mixture toxicity of SN2-reactive soft electrophiles: 3. Evaluation of ethyl α-halogenated acetates with α-halogenated acetonitriles |
| Q69147769 | Multicompartment models of cancer chemotherapy incorporating resistant cell populations |
| Q28709234 | Multicomponent therapeutics of berberine alkaloids |
| Q41472495 | Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients |
| Q33937467 | Network target for screening synergistic drug combinations with application to traditional Chinese medicine |
| Q55475021 | On the significance of telomerase activity in human malignant glioma cells. |
| Q74234923 | Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide |
| Q39621046 | Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5. |
| Q40535280 | Pharmacologic circumvention of multidrug resistance |
| Q55484179 | Positive therapeutic interaction between thiopurines and alkylating drugs in human glioma xenografts. |
| Q37152163 | Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum |
| Q74700006 | Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice |
| Q28546221 | Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines |
| Q72058938 | Quercetin: Synergistic action with carboxyamidotriazole in human breast carcinoma cells |
| Q52248192 | RNA polymerase II transcripts as targets for 5-fluorouridine cytotoxicity: antagonism of 5-fluorouridine actions by alpha-amanitin. |
| Q92282031 | Rationale for Using Irreversible Epidermal Growth Factor Receptor Inhibitors in Combination with Phosphatidylinositol 3-Kinase Inhibitors for Advanced Head and Neck Squamous Cell Carcinoma |
| Q44087789 | Recombinant human interferon-alpha 2a increases hormone receptor level of a human breast carcinoma xenograft in nude mice and enhances the anti-proliferative activity of tamoxifen |
| Q44896258 | Relationships between various uses of antineoplastic drug-interaction terms |
| Q34417585 | Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation. |
| Q41664460 | Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation |
| Q36479416 | Review of the toxicity of chemical mixtures: Theory, policy, and regulatory practice |
| Q42116755 | Rosmarinic Acid and Its Methyl Ester as Antimicrobial Components of the Hydromethanolic Extract of Hyptis atrorubens Poit. (Lamiaceae). |
| Q33738889 | SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib. |
| Q33641643 | SYK regulates mTOR signaling in AML. |
| Q61570960 | Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry |
| Q54417860 | Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations. |
| Q24811833 | Sensitivity of the immature rat uterotrophic assay to mixtures of estrogens |
| Q77809322 | Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model |
| Q58733645 | Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML |
| Q28352779 | Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice |
| Q39734640 | Strong synergy between a eukaryotic antimicrobial peptide and bacteriocins from lactic acid bacteria |
| Q64964305 | Studies on the interaction of placental anticoagulant protein I, beta 2 glycoprotein 1, and antiphospholipid antibodies in the prothrombinase reaction and in the solid phase anticardiolipin assays. |
| Q38998432 | Substrate activity screening with kinases: discovery of small-molecule substrate-competitive c-Src inhibitors |
| Q35994168 | Synergism between a novel amphibian oocyte ribonuclease and lovastatin in inducing cytostatic and cytotoxic effects in human lung and pancreatic carcinoma cell lines |
| Q44164209 | Synergism between rViscumin and cisplatin is not dependent on ERCC-1 expression. |
| Q40995728 | Synergisms with mixtures of xenoestrogens: a reevaluation using the method of isoboles |
| Q64994715 | Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective. |
| Q50587968 | Synergistic action of tiazofurin and genistein on growth inhibition and differentiation of K-562 human leukemic cells. |
| Q36116462 | Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis. |
| Q35596340 | Synergistic cytotoxicity and DNA strand breaks in cells and plasmid DNA exposed to uranyl acetate and ultraviolet radiation |
| Q50587662 | Synergistic down-regulation of signal transduction and cytotoxicity by tiazofurin and quercetin in human ovarian carcinoma cells. |
| Q40209562 | Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: proteomic characterization |
| Q37687654 | Synergistic fibrinolysis: combined effects of plasminogen activators and an antibody that inhibits alpha 2-antiplasmin |
| Q35147474 | Systematic discovery of multicomponent therapeutics |
| Q51934858 | Systems biology and combination therapy in the quest for clinical efficacy. |
| Q49190788 | Systems pharmacology analysis of synergy of TCM: an example using saffron formula. |
| Q37411758 | Systems pharmacology exploration of botanic drug pairs reveals the mechanism for treating different diseases |
| Q60768392 | Tamoxifen synergizes the antiproliferative effect of cisplatin in human ovarian cancer cells: enhancement of DNA platination as a possible mechanism |
| Q42775768 | Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer. |
| Q38958030 | Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy |
| Q37356520 | Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide |
| Q41064243 | Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest |
| Q38822439 | Temozolomide reverses doxorubicin resistance by inhibiting P-glycoprotein in malignant glioma cells |
| Q36326643 | Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals |
| Q52550992 | The combined effects of mixtures of ionizing radiations. |
| Q52400309 | The differential aspects of the linear isobole in the study of combined action of agents. |
| Q41449169 | The evaluation of biological interactions using response surface methodology |
| Q52667906 | The expected effect of a combination of agents: the general solution. |
| Q69035838 | The mechanisms of inhibitory effects of liver extract on lymphocyte proliferation: II. Inhibition of DNA, RNA, and protein synthesis and their relationship to the effects of metabolic inhibitors |
| Q57238244 | The scientific assessment of combined effects of risk factors: different approaches in experimental biosciences and epidemiology |
| Q36689480 | Toll-like receptor 3 in Epstein-Barr virus-associated nasopharyngeal carcinomas: consistent expression and cytotoxic effects of its synthetic ligand poly(A:U) combined to a Smac-mimetic. |
| Q52041372 | Toxicological evaluation of chemical mixtures. |
| Q39753305 | Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance |
| Q35117590 | Treatment of nasopharyngeal carcinoma cells with the histone-deacetylase inhibitor abexinostat: cooperative effects with cis-platin and radiotherapy on patient-derived xenografts |
| Q36470781 | Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma |
| Q35569079 | Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents |
Search more.